ABNB vs ADBE Stock Comparison
Scores Breakdown
| Metric | ABNB | ADBE |
|---|---|---|
| 📈 Growth | 14/30 | 22/30 |
| 💰 Profitability | 18/20 | 17/20 |
| 🏦 Financial Health | 16/20 | 16/20 |
| 💵 Valuation | 13/20 | 12/20 |
| ⚠️ Risk (lower is better) | 7/10 | 4/10 |
| Overall Score | 64/100 | 73/100 |
Side-by-Side Summaries
| ABNB Analysis | ADBE Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver 8 quarters, Revenue declined modestly from $3.732B in Q3 2024 to $3.608B in Q2 2026, while Net Income rose from $461M to $816M, with a peak of $1.374B in Q3 2025 before a mid-year dip. This shows profitability resilience amid revenue variability, driven by episodic operating leverage. Overall, the growth signal is modest on revenue but improving on bottom-line momentum into Q2 2026. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver 8 quarters, revenue rose from $5.714B (Q2 2024) to $6.618B (Q2 2026), up about 16%. Net income grew from $1.712B to $1.889B, with quarterly fluctuations but an overall positive trend. 💰 Margins & Cash FlowGross margin stays in the high 80s to low 90s% (examples: Q4 2025 around 92%, Q2 2026 around 89%). Operating income remains solid near $2.0–$2.3B per quarter. Net cash flow from operating activities is consistently positive, typically around $2.2B–$3.2B per quarter, with occasional stronger quarter (e.g., Q4 2025, $3.16B). Investing/financing flows are mixed but liquidity strong. 🛡️ Balance Sheet & LiquidityCash balances range roughly $5.6B–$7.0B; total assets around $28–$30B; current liabilities in the $9–12B range; long-term debt about $4–$6B; equity around $11.4–$11.8B. Leverage moderate; liquidity ample. ⚠️ Key Drivers & Risks
|